ABEONA THERAPEUTICS INC. Interest and Other Income
ABEONA THERAPEUTICS INC. (ABEO) reported Interest and Other Income of $30.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2022-08-11
- ABEONA THERAPEUTICS INC. interest and other income for the quarter ending 2022-06-30 was $30.00K, a 275.00% increase year-over-year.
- ABEONA THERAPEUTICS INC. interest and other income for the quarter ending 2021-06-30 was $8.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month |
|---|---|---|
| 2022-06-30 | $30.00K 10-Q · filed 2022-08-11 | $31.00K 10-Q · filed 2022-08-11 |
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-11 | $23.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |